Medicaid -

MMWR Booster for: State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2018–2022 / Weekly / April 11, 2024 / 73(14);301–306

Posted on April 12, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Increased Comprehensive Coverage: From 2018 to 2022, states with comprehensive Medicaid coverage of tobacco cessation treatments rose from 15 to 20, while those without any treatment access

MMWR Booster for: Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents — Selected U.S. States, 2019, Weekly / September 30, 2022 / 71(39);1241–1246

Posted on February 1, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways In 2019, less than half of Medicaid enrollees aged 2–16 with Sickle Cell Anemia (SCA) received recommended transcranial Doppler (TCD) screening, crucial for stroke risk identification. Hydroxyurea

Epidemiology, Broadly Speaking

Tag: Medicaid